Intraoperative Dual-modality Imaging in Renal Cell Carcinoma

NCT02497599 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Indium-111-DOTA-Girentuximab-IRDye800CW
RADIATION: SPECT/CT
PROCEDURE: Intraoperative dual-modality imaging

Sponsor

Radboud University Medical Center